brain imaging – mycolab.ai

If psychedelics heal, how do they do it?

mycolabadmin

Psychedelic drugs like MDMA and magic mushrooms are showing remarkable promise in treating serious mental health conditions like PTSD and depression, with clinical trials demonstrating higher success rates than traditional therapy alone. However, scientists still don’t fully understand how these drugs work at the molecular and brain level, or whether the hallucinations they produce are necessary for healing. Researchers are investigating whether modified versions without hallucinations could provide the same benefits while being easier to administer, while also exploring how individual factors and treatment environment affect outcomes.

Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review

mycolabadmin

This research review examines how psilocybin, a compound from certain mushrooms, may help treat depression by creating changes in both brain function and psychological experience. Within supportive therapeutic settings, psilocybin appears to increase cognitive flexibility, help people better process emotions, and restore a sense of connection to themselves, others, and the world. The antidepressant benefits seem to work through a combination of direct brain changes and psychotherapeutic factors, rather than through pure pharmacological action alone.

Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans

mycolabadmin

This comprehensive review examines how scientists use advanced imaging techniques like PET and SPECT scans to study how hallucinogenic drugs such as LSD and psilocybin interact with the brain. The research shows these drugs primarily bind to serotonin receptors, particularly the 5-HT2A subtype, which appear responsible for producing hallucinations. While scientific understanding of hallucinogen mechanisms has advanced significantly, there is still much to learn about their complete effects on brain chemistry and their potential therapeutic applications.

A review of the neuroscience of religion: an overview of the field, its limitations, and future interventions

mycolabadmin

This review examines how neuroscience studies the brain’s role in religious experiences and behaviors. While current brain imaging technology has revealed connections between specific brain regions and religious practices like prayer and meditation, these technologies limit what researchers can study because they require people to stay still. The authors suggest that newer technologies like functional near-infrared spectroscopy could allow scientists to study the full range of religious behaviors, including movement-based rituals that are important to many faiths.

Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression

mycolabadmin

This research study is investigating how psilocybin, a compound from certain mushrooms, affects the brain in people with depression. The study involves 50 participants who will receive either psilocybin or a placebo, with their brain activity monitored using advanced imaging scans. Researchers will examine how psilocybin changes blood flow and network activity in brain regions involved in mood regulation, and whether these changes are linked to improvements in depression symptoms.

Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms

mycolabadmin

Psilocybin, a compound from certain mushrooms, is being studied as a potential rapid-acting treatment for severe depression that doesn’t respond to standard antidepressants. Unlike conventional antidepressants that take weeks to work, psilocybin shows promise for producing mood improvements within days. The drug works by activating serotonin receptors in the brain and promoting the growth of new neural connections, though researchers are still working to fully understand how it achieves its antidepressant effects.

The Neural Signature of Visual Learning Under Restrictive Virtual-Reality Conditions

mycolabadmin

Scientists studied how honey bees learn to distinguish different colors in a virtual reality environment. By examining the brains of bees that successfully learned versus those that didn’t, researchers found that successful learning caused specific genes to be turned down in key visual brain regions. This suggests that learning involves not just turning genes on, but also turning some off, which may help the brain focus on important visual information. The findings help us understand how animal brains process visual information and learn from experience.

Research Topic: brain imaging

If psychedelics heal, how do they do it?

Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review

Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans

A review of the neuroscience of religion: an overview of the field, its limitations, and future interventions

Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression

Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms

The Neural Signature of Visual Learning Under Restrictive Virtual-Reality Conditions